Inter Biosolutions ApS: Financial statements 2022
CVR: 43014757
Source: annual report 2022, Danish Business Authority
26/01/2022 – 31/12/2022
Inter Biosolutions ApS (CVR 43014757) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -8,170 and a net result of DKK -8,311. Equity in the 2022 report amounted to DKK 33,689. The solvency ratio was 24.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK -8,170
- Profit/Loss
- DKK -8,311
- Equity
- DKK 33,689
- Total Assets
- DKK 135,736
Keep an eye on Inter Biosolutions ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of January 26, 2022, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Inter Biosolutions ApS.
As of January 26, 2022, Carsten Pedersen Rise is registered as director of Inter Biosolutions ApS.
Inter Biosolutions ApS was founded on January 26, 2022.
About Inter Biosolutions ApS
Inter Biosolutions ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Inter Biofuel ApS. The management consists of Klaus Hjortenberg Kroll. The company is owned by STEEN BRUMMERSTEDT IVERSEN ApS and Kobo ApS. In 2025, the company reported a gross profit of DKK 1,732,251 and a net result of DKK -1,516,000 compared with DKK -485,946 the year before. Equity in the 2025 report amounted to DKK 1,017,129.